MRI biomarkers in osseous tumors
- 30 January 2019
- journal article
- review article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 50 (3) , 702-718
Abstract
Although radiography continues to play a critical role in osseous tumor assessment, there have been remarkable advances in cross‐sectional imaging. MRI has taken a lead in this assessment due to high tissue contrast and spatial resolution, which are well suited for bone lesion assessment. More recently, although somewhat lagging other organ systems, quantitative parameters have shown promising potential as biomarkers for osseous tumors. Among these sequences are chemical shift imaging (CSI), apparent diffusion coefficient (ADC), and intravoxel incoherent motion (IVIM) from diffusion‐weighted imaging (DWI), quantitative dynamic contrast enhanced (DCE)‐MRI, and magnetic resonance spectroscopy (MRS). In this article, we review the background and recent roles of these quantitative MRI biomarkers for osseous tumors.Level of Evidence: 3Technical Efficacy Stage: 3J. MAGN. RESON. IMAGING 2019. J. Magn. Reson. Imaging 2019;50:702–718.Keywords
This publication has 104 references indexed in Scilit:
- Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRIMagnetic Resonance Imaging, 2013
- Noninvasive Assessment of Response to Neoadjuvant Chemotherapy in Osteosarcoma of Long Bones with Diffusion-Weighted Imaging: An Initial In Vivo StudyPLOS ONE, 2013
- Comparison of Qualitative and Quantitative Evaluation of Diffusion-Weighted MRI and Chemical-Shift Imaging in the Differentiation of Benign and Malignant Vertebral Body FracturesAmerican Journal of Roentgenology, 2012
- Dynamic contrast-enhanced imaging techniques: CT and MRIBritish Journal of Radiology, 2011
- The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficientSkeletal Radiology, 2009
- Longitudinally Monitoring Chemotherapy Effect of Malignant Musculoskeletal Tumors With In Vivo Proton Magnetic Resonance SpectroscopyJournal of Computer Assisted Tomography, 2008
- Tumor Necrosis Rate Adjusted by Tumor Volume Change Is a Better Predictor of Survival of Localized Osteosarcoma PatientsAnnals of Surgical Oncology, 2007
- In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrowMagnetic Resonance Materials in Physics, Biology and Medicine, 2007
- Evaluation of diffusion‐weighted imaging for the differential diagnosis of poorly contrast‐enhanced and T2‐prolonged bone masses: Initial experienceJournal of Magnetic Resonance Imaging, 2006
- Musculoskeletal tumors: Use of proton MR spectroscopic imaging for characterizationJournal of Magnetic Resonance Imaging, 2005